Clinical and epidemiological manifestations of inflammatory diseases of the intestine associated with Cl. difficile
About the Authors
D. S. Purgina
St. Petersburg Pasteur Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
St. Petersburg
L. V. Lyalina
St. Petersburg Pasteur Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
St. Petersburg
V. V. Rassokhin
St. Petersburg Pasteur Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
St. Petersburg
References
1. Danilova N.A. Bacterial overgrowth syndrome in patients with inflammatory bowel diseases. Practical Medicine, 2015, No. 6 (91), pp. 122–126 (In Russ.).
2. Trifan A. еt al. Impact of Clostridium difficile infection on inflammatory bowel disease outcome: a review // World J. Gastroenterol. 2014. Sep. 7; Vol. 20, No. 33. Р. 11736–11742. doi: 10.3748/wjg.v20.i33.11736.
3. Rodríguez C. et al. Microbiota insights in clostridium difficile infection and inflammatory bowel disease // Gut Microbes. 2020. Nov 9; Vol. 12, No. 1. Р. 1725220. doi: 10.1080/19490976.2020.1725220.
4. Knyazev O.V. Correction of intestinal microflora in patients with ulcerative colitis. Experimental and clinical gastroenterology, 2011, No. 5, рр. 91–96 (In Russ.).
Review
For citations:
Purgina D.S., Lyalina L.V., Rassokhin V.V. Clinical and epidemiological manifestations of inflammatory diseases of the intestine associated with Cl. difficile. HIV Infection and Immunosuppressive Disorders. 2023;15(1):74-76. (In Russ.)
Views:
222
.png)
Email this article 